文献速递肺结节与肺癌

住宅氡暴露与从不吸烟肺癌患者EGFR突变及ALK重排的关系

Residential radon, EGFR mutations and ALK alterations in never-smoking lung cancer cases.
PubMed 文献 · Eur Respir J · 2016-10-06

本研究在西班牙加利西亚高氡地区开展多中心病例对照研究,仅纳入肺癌病例,共323例,中位年龄70岁,男性占19.5%。比较有无EGFR突变或ALK重排患者的住宅氡中位水平,发现ALK阳性患者住宅氡水平约为阴性者的两倍,但EGFR突变状态间无差异。提示住宅氡可能影响从不吸烟者肺癌的分子特征,但需更大样本研究验证。

要点

  • 从不吸烟肺癌患者中,ALK阳性者住宅氡水平约为阴性者的两倍(290 vs 164 Bq·m-3)。
  • EGFR外显子19缺失患者住宅氡水平约为外显子21 L858R突变者的两倍(216 vs 118 Bq·m-3,p=0.057)。
  • EGFR突变状态与住宅氡水平无显著差异,ALK阳性患者比阴性者年轻10岁。

核心结论

  • 住宅氡可能参与从不吸烟者肺癌的分子特征形成,但需更大样本研究支持。

研究设计与样本

  • 多中心病例对照研究,仅纳入肺癌病例,位于西班牙加利西亚高氡地区,共323例,中位年龄70岁,男性占19.5%。

主要发现

  • 42%患者EGFR阳性,15%患者ALK阳性;最常见EGFR改变为外显子19缺失和外显子21 L858R单点替换突变。
  • ALK阳性患者比ALK阴性患者年轻10岁。
  • 外显子19缺失患者住宅氡中位水平为216 Bq·m-3,外显子21 L858R突变者为118 Bq·m-3(p=0.057)。
  • EGFR突变状态间住宅氡水平无差异。
  • ALK阳性患者(n=12)住宅氡中位水平为290 Bq·m-3,ALK阴性患者为164 Bq·m-3。

关键数值与推荐

  • 外显子19缺失 vs 外显子21 L858R:住宅氡中位水平216 vs 118 Bq·m-3,p=0.057。
  • ALK阳性 vs 阴性:住宅氡中位水平290 vs 164 Bq·m-3。

临床怎么用

  • 对从不吸烟肺癌患者,尤其ALK阳性者,可关注住宅氡暴露史作为分子特征分析的参考信息。

局限性

  • 研究仅纳入肺癌病例,样本量有限,尤其ALK阳性患者仅12例,需更大样本研究验证。

以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。

原文

The aim of this study was to assess if residential radon exposure might cause EGFR mutations or ALK rearrangements in never-smokers.We designed a multicentre case-control study in a radon-prone area (Galicia, Spain); only lung cancer cases were included in the study. We obtained residential radon measurements and clinical information for all the participants. We compared the median values of residential radon between patients with EGFR mutations or ALK rearrangements versus those without them.323 patients were included. Median age was 70 years and 19.5% were males. 42 and 15% of patients were EGFR- and ALK-positive, respectively. The most frequent EGFR alterations were exon 19 deletions and exon 21 (L858R) single-point substitution mutations. ALK-positive patients were 10 years younger than ALK-negative patients. Residential radon levels were two-fold higher in patients with exon 19 deletions compared with patients with exon 21 (L858R) single-point substitution mutations (216 versus 118 Bq·m-3; p=0.057). There were no differences in residential radon levels by EGFR mutation status. ALK-positive patients (n=12) essentially had two-fold residential radon levels compared with ALK-negative patients (290 versus 164 Bq·m-3, respectively).Residential radon may have a role in the molecular signature of lung cancer in never-smokers, although more studies with larger sample sizes are needed to support this hypothesis.

来源:Eur Respir J,查看原文。版权归原作者所有。

引用

  1. Ruano-Ravina A, Torres-Durán M, Kelsey KT, et al. Residential radon, EGFR mutations and ALK alterations in never-smoking lung cancer cases. Eur Respir J. 2016. PMID: 27799390. doi:10.1183/13993003.00407-2016

供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。